Skip to main content
TipRanks
Go Ultimate75% OFF

MPH Health Care AG (93M1) AI Stock Analysis

1 Followers
CH:93M1

MPH Health Care AG

(BX Swiss:93M1)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Conservative balance sheetLow leverage gives MPH substantial financial flexibility because limited debt reduces interest and refinancing pressure. This stronger balance-sheet position can help the holding company withstand volatility in portfolio values, support selective investment decisions, and preserve capacity for distributions or future growth.
Negative Factors
Highly erratic revenueThe sharp negative growth rate and historically erratic revenue pattern make the top line difficult to forecast over the next several quarters. This instability can reduce confidence in recurring earnings power and complicate capital allocation, distribution planning, and assessment of underlying portfolio momentum.

MPH Health Care AG Business Overview & Revenue Model

Company Description

MPH Health Care AG is a German-based investment firm with a primary focus on the healthcare sector. The company's portfolio includes the production and distribution of medicinal products designed to treat serious illnesses like cancer, HIV, and vario...

MPH Health Care AG Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

CH:93M1 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
DE:DMPDE:DMP54NeutralEUR 1.73B14.0420.60%2.50%1.71%15.95%
DE:B8FKDE:B8FK53NeutralEUR 18.23M-1.75-110.30%―――
DE:EVTDE:EVT50NeutralEUR 555.01M-2.91-25.63%―-5.03%-13.63%

* Financial Sector Average

Performance Comparison

0%500%1000%DE:B8FKDE:EVTDE:PA8DE:DMPDE:SBXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CH:93M1 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:B8FKBiofrontera AG2.770.062.21%
DE:EVTEvotec AG (UK)2.97-2.25-43.11%
DE:PA8PAION AG0.050.03283.33%
DE:DMPDermapharm Holding35.251.143.35%
DE:SBXSynBiotic SE0.12-2.06-94.31%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.